📢PBS Listing ANNOUNCEMENT📢 Life-changing news for Australians living with metastatic breast cancer! Starting from TOMORROW (1st October, 2025) Truqap® (capivasertib) is now listed on the PBS for HR-positive, HER2-negative locally advanced or metastatic breast cancer. This means more accessible treatment for those who have progressed after endocrine therapy, helping improve outcomes and hope for thousands of Australians.
